ANIKA THERAPEUTICS, INC. EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • May 8th, 2024 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Anika Therapeutics, Inc., a Delaware corporation (the “Company”), and Stephen Griffin (the “Executive”) enter into this Executive Retention Agreement (the “Agreement”) dated as of June 3, 2024 (the “Effective Date”).
Re: Transitional Services and Separation AgreementTransitional Services and Separation Agreement • May 8th, 2024 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This letter agreement follows our conversations regarding your employment with Anika Therapeutics, Inc. (the “Company”). This confirms that you will be transitioning and resigning from your employment. We appreciate your contributions and would like to work with you to make this transition as smooth as possible. Consistent with that, this letter is to express the parties’ mutual understanding and promises concerning the orderly transition of your responsibilities and the ultimate termination of your employment at the Company.
